The centre will cater to a wide range of patients requiring transplants for various conditions, including leukaemia, lymphoma, multiple myeloma, aplastic anaemia, thalassemia
Apollo Cancer Centre (ACC), Bannerghatta Road, Bengaluru, has launched its dedicated Apollo Cellular Therapy and Blood and Marrow Transplant Center.
The launch event was attended by Dr Neema Bhat, Senior Consultant Hematology BMT Physician and Paediatric Oncology; Prof Dr Vijay Agarwal, Senior and Lead consultant - Medical Oncology, Prof Dr Vishwanath S - Senior Consultant and Academic Advisor - Medical Oncology and Haemato oncology; Dr Poonam Maurya, Senior consultant Medical Oncology and Hemato Oncology; Dr Aditya Murali, Senior Consultant – Medical Oncology and Hemato Oncology. Akshay Oleti, CEO – Karnataka Region, Apollo Hospitals, was also present.
Dr Neema Bhat said, "The new centre will cater to a wide range of patients requiring transplants for various conditions, including leukaemia, lymphoma, multiple myeloma, aplastic anaemia, thalassemia, and other complex hematologic disorders."
Prof Dr Vishwanath S mentioned, "A dedicated cellular therapy and transplant programme must function on clinical discipline. What sets this centre apart is its focus on protocol fidelity, academic oversight, and rigorous infection-control systems. These elements are fundamental to delivering transplants safely and consistently within a well-structured clinical environment.”
Prof Dr Vijay Agarwal said “The future of cancer treatment lies in harnessing the body’s own cells to fight disease. With the establishment of this centre, we are creating an ecosystem that combines advanced research, clinical expertise, and compassionate care. Our focus is not only on performing transplants but also on developing next-generation cellular therapies that can transform outcomes in both malignant and non-malignant conditions.”
Akshay Oleti opined, "The launch of this state-of-the-art Centre is a testament to our focus on enhancing Karnataka’s healthcare infrastructure. With this new facility, we aim to expand access to complex haematology and transplant services for the patients in the State. Our endeavour is to ensure that every patient receives world-class care within their own state, supported by Apollo’s legacy of trust and excellence.”
Dr Poonam Maurya said, “One of the most overlooked challenges in transplant medicine is the sheer logistical strain on families—frequent consultations, complex investigations, and prolonged admissions. By integrating diagnostics, transplant services, and structured post-transplant follow-up within a single ecosystem, this centre will substantially reduce that load and ensure a more streamlined and supportive care experience.”
Dr Aditya Murali said, “Cellular therapies are evolving at a remarkable pace, spanning allogeneic and haploidentical transplants to increasingly sophisticated immune-engineered interventions. Delivering these modalities requires controlled environments, multidisciplinary coordination, and strict adherence to validated clinical protocols. This facility strengthens our ability to administer such therapies with the precision they demand.”
